Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


ELEKT-D: Electroconvulsive Therapy (ECT) vs. Ketamine in Patients With Treatment Resistant Depression (TRD)


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT03113968

Organisation Name: The Cleveland Clinic

Overal Status: Recruiting

Start Date: April 7, 2017

Last Update: September 4, 2020

Lead Sponsor: The Cleveland Clinic

Brief Summary: The goal of the study is to conduct a comparative randomized trial of electroconvulsive therapy (ECT) vs. ketamine for patients with treatment resistant depression (TRD) in a real world setting with patient reported outcomes as primary and secondary outcome measures.

Conditions:
  • Treatment Resistant Depression
  • Electroconvulsive Therapy
  • ECT
  • Ketamine
  • Psychiatric Disorder
  • Depression
  • Major Depressive Disorder
  • Major Depressive Episode
  • Unipolar Depression


Total execution time in seconds: 0.20418190956116